Pricing Log in Create free account

CytomX Therapeutics, Inc. (CTMX) vs Faeth Therapeutics, Inc. (FTH)

CytomX Therapeutics, Inc. and Faeth Therapeutics, Inc. are both Biotechnology companies. CytomX Therapeutics, Inc. and Faeth Therapeutics, Inc. are of similar size ($532.3M and $525.1M). Faeth Therapeutics, Inc. has the higher net margin (0.00% vs −451.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Faeth Therapeutics, Inc. leads on 7 and CytomX Therapeutics, Inc. on 5.

Valuation

Metric CTMX FTH Biotechnology median
P/E n/m n/m 8.50
P/S 27.16 n/m 9.71
P/B 1.65 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.32 0.64
EV/Sales 9.28 n/m 9.21
Earnings yield (22.03%) (753.86%) (33.15%)
Free cash flow yield (16.63%) (31.94%) (25.50%)

Profitability

Metric CTMX FTH Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (476.19%) 0.00% 0.00%
Net margin (451.62%) 0.00% 0.00%
Free cash flow margin (450.27%) 0.00% 0.00%
Return on equity (39.18%) (195.26%) (56.36%)
Return on assets (29.72%) (176.88%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CTMX FTH Biotechnology median
Revenue growth (TTM) (87.03%) — 6.02%
EPS growth (last fiscal year) (139.47%) 30.33% 30.26%
Revenue growth, 5-year CAGR (5.36%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTMX FTH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.36 19.69 4.72
Net debt to EBITDA 5.91 0.96 0.96

Dividend

Metric CTMX FTH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CTMX FTH Biotechnology median
Market cap 525.14m 532.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack